首页> 美国卫生研究院文献>Journal of Nucleic Acids >Novel Indolocarbazole Derivative 12-(α-L-arabinopyranosyl)indolo23-apyrrolo34-ccarbazole-57-dione Is a Preferred c-Myc Guanine Quadruplex Ligand
【2h】

Novel Indolocarbazole Derivative 12-(α-L-arabinopyranosyl)indolo23-apyrrolo34-ccarbazole-57-dione Is a Preferred c-Myc Guanine Quadruplex Ligand

机译:新型吲哚并咔唑衍生物12-(α-L-阿拉伯吡喃糖基)吲哚并23-a吡咯并34-c咔唑-57-二酮是优选的c-Myc鸟嘌呤四元配体

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The indolocarbazole derivative 12-(α-L-arabinopyranosyl)indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7-dione (AIC) has demonstrated a high potency (at nanomolar to submicromolar concentrations) towards the NCI panel of human tumor cell lines and transplanted tumors. Intercalation into the DNA double helix has been identified as an important prerequisite for AIC cytotoxicity. In this study, we provide evidence for preferential binding to the G-quadruplex derived from the c-Myc oncogene promoter (Pu18 d(AG3TG4)2; G-c-Myc). The association constant for AIC:G-c-Myc complex was ~100 times and 10 times greater than the respective values for the complexes AIC:c-Myc duplex and AIC:telomeric d(TTAGGG)4 G-quadruplex. The concentrations at which AIC formed complexes with G-c-Myc were close to those that attenuated the steady-state level of the c-Myc mRNA in the human HCT116 colon carcinoma cell line. We suggest that preferential binding of AIC to G-c-Myc rather than to the c-Myc duplex might favor the quadruplex formation in the cells, thereby contributing to downregulation of the c-Myc expression by AIC.
机译:吲哚并咔唑衍生物12-(α-L-阿拉伯吡喃糖基)吲哚并[2,3-a]吡咯并[3,4-c]咔唑-5,7-二酮(AIC)具有很高的效力(在纳摩尔至亚微摩尔浓度下)朝向人类肿瘤细胞系和移植肿瘤的NCI组。已确定插入DNA双螺旋结构是AIC细胞毒性的重要前提。在这项研究中,我们提供证据证明优先结合c-Myc癌基因启动子(Pu18 d(AG3TG4)2; G-c-Myc)产生的G-四链体。 AIC:G-c-Myc复合物的缔合常数比AIC:c-Myc双链体和AIC:端粒d(TTAGGG)4 G-四链体的相应值大100倍和10倍。 AIC与G-c-Myc形成复合物的浓度接近于减弱人HCT116结肠癌细胞系中c-Myc mRNA稳态水平的浓度。我们建议AIC优先绑定到G-c-Myc而不是c-Myc双链体可能会促进细胞中四链体的形成,从而有助于AIC对c-Myc表达的下调。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号